Industry

The transaction with Ascension Illinois further establishes Prime Healthcare as a leader committed to ensuring health equity and clinically excellent healthcare ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare has entered into an asset purchase agreement with Ascension for the sale of Ascension Illinois hospitals, associated physician practices, post-acute and senior living facilities. Upon completion, this acquisition will be … [Read more…]

Strong underlying growth supports FY 2024 guidance upgrade, with both Total Revenue and Core EPS now expected to increase by a mid teens percentage at CER1 CAMBRIDGE, United Kingdom–(BUSINESS WIRE)–AstraZeneca: Revenue and EPS summary H1 2024 % Change   Q2 2024 % Change $m Actual CER   $m Actual CER – Product Sales 24,629 15 … [Read more…]

MINNETONKA, Minn.–(BUSINESS WIRE)–A.forall’s U.S. subsidiary Milla Pharmaceuticals Inc. announced the launch of the group’s generic version of Precedex®, Dexmedetomidine Hydrochloride Injection 200 mcg per 50 mL and 400 mcg per 100 mL in 0.9% sodium chloride in glass bottles by its partner Sagent Pharmaceuticals. Dexmedetomidine Hydrochloride Injection is indicated for sedation of initially intubated and … [Read more…]

Detailed results from the phase III ARCADIA 1 and 2 trials evaluating the safety and efficacy of nemolizumab in atopic dermatitis were published for the first time in The Lancet1 Data from this phase III program demonstrate the potential of nemolizumab (in combination with background therapy) to improve key aspects of atopic dermatitis; skin lesions, … [Read more…]

GREENBRAE, Calif.–(BUSINESS WIRE)–#Marin—MarinHealth announced today that it performed its first vascular surgical procedure for aneurysm repair utilizing advanced AI technology. Allan Conway, MD, Clinical Associate Professor of Vascular and Endovascular Surgery, UCSF and MarinHealth, and the vascular surgical team applied Cydar Maps augmented artificial intelligence technology, making the MarinHealth vascular surgical team one of few … [Read more…]

PHOENIX–(BUSINESS WIRE)–Dr. Ali Rodriguez, OB-GYN, shares insights on the major concerns and advancements in contraceptive options available today, emphasizing the importance of access and education for all women. “Many women in the U.S. are experiencing anxiety and uncertainty about their ability to manage and make decisions about their reproductive health and the healthcare options available … [Read more…]

FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it will release its second quarter 2024 financial results on Wednesday, August 7, 2024. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time … [Read more…]

HUNT VALLEY, Md.–(BUSINESS WIRE)–Omega Healthcare Investors, Inc. (NYSE:OHI) today announced the quarterly dividend on its common stock and its second quarter earnings release date. Quarterly Dividend Declaration Omega today announced that the Company’s Board of Directors declared a cash dividend of $0.67 per share on its common stock. The dividend is payable Thursday, August 15, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Europe Sleep Apnea Devices Market Report by Types, Therapeutic Devices, Diagnostic Devices, End User, and Company Analysis 2024-2032” report has been added to ResearchAndMarkets.com’s offering. Europe sleep apnea devices market turned into US$ 1.81 billion in 2023 and is expected to reach US$ 3.53 billion by 2032, with a CAGR of 7.70% from … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Wednesday, July 31, 2024 to report its second quarter 2024 financial results and provide a business … [Read more…]